Product name: Tripeptide VPY
Counter ion: Trifluoacetate
Format: Lyophilized powder
Description: Tripeptide VPY is a novel PepT1 substrate that can inhibit the production of pro-inflammatory mediators in vitro in intestinal epithelial and immune cells, and reduce the severity of colitis in mice by down-regulating the expression of pro-inflammatory cytokines in the colon, suggesting that VPY may be promising for the treatment of IBD.
Usage: For Scientific Research Use Only, Not for Human Use.